Apoptosis is an important component of normal tissue physiology, and the prompt removal of apoptotic cells is equally essential to avoid the undesirable consequences of their accumulation and disintegration. Professional phagocytes are highly special- 
| TISSUE POSITIONING OF PHAGOCYTES AT SITES OF FREQUENT APOPTOSIS
The orchestrated process of apoptotic cell clearance enables macrophages to locate apoptotic cells within tissues, accurately identify apoptotic cells from viable cells, and initiate their prompt engulfment without interrupting tissue function. For example, in the brain where long-range identification of apoptotic neurons is paramount such as not to disrupt neuronal synapses, the fractalkine receptor CX3CR1 is highly expressed on microglia, the resident macrophages in the brain, and these cells also express high levels of MFG-E8, BAI1, TIM4, and TAM receptors. 2, 21, 22 Microglia are abundant within the dentate gyrus, the site of neurogenesis where large numbers of neural progenitors undergo apoptosis during differentiation into neurons. [23] [24] [25] Such strategic positioning of macrophages in locations of frequent apoptosis is notable in all tissues, and the location reflects developmental patterns and physiology distinct to each tissue [reviewed in (26) ]. In the testis, macrophages are located within the interstitium and along seminiferous tubules, but their numbers are highest where undifferentiated spermatogonia concentrate. 27 Spermatogenesis is associated with apoptosis of a large proportion of spermatogenic cells, 28 and while prompt phagocytosis of these cells can conceivably be conducted by testicular macrophages, this task has so far been assigned to specialized Sertoli cells. These somatic lineage cells nurse spermatogenesis and are located within the seminiferous epithelium alongside developing germ cells. 28 Sertoli cells express all three TAM receptors whose signaling is crucial for clearance of apoptotic germ cells during spermatogenesis. 5 Sertoli cells also rely on a signaling pathway downstream of BAI involving the cytoplasmic protein Elmo1, which functions with DOCK1 as a guanine nucleotide exchange factor for the GTPase Rac1 to promote actin cytoskeletal rearrangement and apoptotic cell phagocytosis. 29 Testicular macrophages, on the other hand, express components of the colony-stimulating factor 1 and retinoic acid pathways to support spermatogonial differentiation. 27 "Tingible body" macrophages, a familiar term referring to macrophages containing apoptotic cells or apoptotic cell fragments, are most notable in germinal centers within secondary lymphoid organs after the peak of an immune response when almost 10% of plasma cells undergo apoptosis. 30 Notably, the number of "tingible body" macrophages is reduced in the germinal centers of several patients with SLE 31 reflecting the impaired clearance of apoptotic cells in this disease.
Despite the large numbers of cells that undergo apoptosis in tissues on a daily basis, especially in tissues such as the intestine where these numbers in humans approximate 10 10 daily, 32 to antigen-specific CD8 T cells leading to their deletion as a mechanism of immune tolerance. 33, 34 Within the pancreatic lymph nodes, CD11c + CD11b + CD8α − DC were found carrying fluorescently labeled dead cells that had been injected directly into the pancreas. 35 Intrapancreatic injection of dead β-islet cells promoted activation of β cellreactive T cells, and this was also the case upon the induction of β cell death in vivo via injection of Streptozotocin, a cytotoxic chemical that β cells are sensitive to. 35 Sub-capsular sinus macrophages lining the lymphatic endothelium overlying B cell follicles were found to capture subcutaneously injected apoptotic cells in an experimental setting. 36 Within the lung parenchyma where DC subsets are in intimate contact with the bronchial and alveolar epithelium, 37, 38 only the DC subset characterized by expression of the E-cadherin-binding integrin αE (CD103) captured intra-nasally delivered apoptotic thymocytes and trafficked these apoptotic cells to the draining lymph nodes for cross-presentation of apoptotic cell-derived antigens to CD8 T cells. 36 The nature of phagocyte that recognizes, samples and/or internalizes apoptotic cells is likely dependent on the tissue and its physiological state at any given time.
| VISUALIZING CLEARANCE OF CELLS UNDERGOING APOPTOSIS IN SITU
Rapid turnover of intestinal epithelial cells (IEC) every 4-5 days marks the intestinal epithelium as a site of increased apoptosis during homeostatic conditions, 32 and identifies it as an ideal setting for studying apoptotic cell clearance in vivo. Using a mouse model where expression of a transgene encoding an enhanced green fluorescent protein (eGFP) and diphtheria toxin receptor (DTR) fusion protein is directed specifically to IECs, the fate of IEC after apoptosis in situ could be visualized. 39 The model is referred to as the VDTR mouse. 39 The DTR enables the experimental induction of apoptosis as was determined by administering a carefully titrated concentration of diphtheria toxin that increased the levels of apoptosis over background. 39 This leads to the sensitive capture of a larger number of phagocytes in the act of apoptotic IEC uptake, and importantly without causing inflammation or disrupting homeostatic conditions. 39 The transgenic VDTR mouse model enabled visualization of phagocytes that had engulfed cells undergoing apoptosis in situ. The studies showed that within a heterogeneous network of intestinal lamina propria phagocytes, 40, 41 both subsets of macrophages and a single CD103 + subset out of three DC subsets are responsible for apoptotic IEC sampling. 39 These phagocytes are appropriately positioned for the task; facing the basolateral surface of IEC and capable of extending their dendrites through epithelial tight junctions to sample luminal contents, commensal bacteria, 41, 42 , and apoptotic IEC. 39 After the administration of diphtheria toxin to VDTR mice, both macrophage subsets within the small intestinal lamina propria, identified as CD103
sampled the bulk of apoptotic IEC over time. 39 Because the content of eGFP + cargo identifies phagocytes that had sampled apoptotic IEC, the cells could be subjected to fluorescent activated cell sorting and their transcriptional profiles could then be compared to their eGFP devoid counterparts. A snapshot could be taken over time after the induction of apoptosis to determine the transcriptional changes in phagocytes upon apoptotic cell sampling. 39 Analysis of the phagocyte transcriptomes revealed specialized responses, which will be considered next within the larger context of functions phagocytes are known to conduct in response to apoptotic cell sampling.
The first finding from studying the gene expression profiles of phagocytes bearing apoptotic cells was the distinct patterns of expression of apoptotic cell engulfment receptors by macrophages vs the CD103 + DC. 39 The CD103 + DC upregulated the gene encoding CD205 which has been reported to detect apoptotic cell ligands, 43 while macrophages upregulated genes involved in apoptotic cell clearance including genes encoding the scavenger receptor CD163, the bridge molecule Gas6 and the TAM receptor Mer. 39 Other genes were also differentially expressed in macrophages vs CD103 + DC in- 55 and the ability of apoptotic cells to suppress monocyte production of pro-inflammatory cytokines and induce expression of the anti-inflammatory cytokine IL-10 in response to lipopolysaccharide (LPS). 56 Other studies at the time reported the resolution of acute inflammation by apoptotic cells in vivo, 57, 58 and this was attributed to the increased levels of the immunosuppressive cytokine TGF-β.
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Apoptotic cells themselves have been reported to produce IL-10 and TGF-β during the process of dying. 61, 62 Several studies have demonstrated the induction of immune tolerance in different settings in response to DC phagocytosis of apoptotic cells [reviewed in (63, 64) ].
The therapeutic potential of apoptotic cell-induced immunosuppression has been explored based on data in animal models demonstrating effective control of chronic inflammation in the settings of allograft rejection and graft-versus-host disease, 65, 66 diabetes, 67 arthritis, [68] [69] [70] [71] septic shock, 72 and other chronic and acute inflammatory condi- Another set of receptors that have been associated with the immunosuppressive effects of apoptotic cells are the nuclear hormone receptors peroxisome-proliferator-activated receptor (PPAR) and liver x receptor (LXR). These receptors are additionally important for apoptotic cell clearance. [84] [85] [86] [87] The first report implicating PPARγ in apoptotic cell-induced immunosuppression demonstrated its activation in response to apoptotic cell uptake, and its attenuation of reactive oxygen species production by inflammatory peritoneal macrophages. 84 The homeostatic clearance of apoptotic neutrophils has been linked to LXR such that neutrophils accumulate within the blood and tissues of LXR-deficient mice. 88, 89 Interestingly, LXR activation upon apoptotic neutrophil engulfment represses transcription of the inflammatory cytokine IL-23, 89 and in this manner controls the levels of neutrophils in the blood by targeting the upstream regulator of IL-17 and granulocyte colony-stimulating factor (G-CSF) that are important for granulopoiesis. 90 Global or macrophage-specific deletion of PPARδ or deficiency in LXRα/β or retinoid X receptor (RXR)α, which heterodimerize with LXR, leads to defects in apoptotic cell clearance in vivo and consequent increases in serum levels of autoantibodies with progressive lupus-like autoimmune disease. 85, 87, 91 The phenotype of these mice is similar to that of mice with impaired apoptotic cell removal. 92 Apoptotic cell uptake by PPARδ, RXRα, or LXRα/β deficient macrophages is unable to suppress LPS-induced IL-12, TNF-α, or IL-1β transcription and synthesis, and fails to induce TGF-β and IL-10 synthesis demonstrating that PPARδ, RXRα, and LXR contribute to the anti-inflammatory response induced by apoptotic cells. 85, 87, 91 Lastly, Nr4a1, a member of the Nr4a subfamily of nuclear receptors is induced in resident peritoneal macrophages in response to the phagocytosis of apoptotic cells in a PS-dependent manner. 
| Subset-specific pathways of suppressing inflammation
The studies tracking apoptotic IEC into small intestinal lamina propria phagocytes have shown that phagocytes adopt two prominent transcriptional signatures in response to apoptotic cells: the "downregulation of inflammatory genes" and "suppression of the immune response". 39 No upregulated genes were shared among these phagocytes, and only two genes were down-modulated by all three subsets 39 : Plac8 implicated in clearance of certain microorganisms, 94 and
Itgb7 encoding integrin-β7 that mediates homing to gut-associated lymphoid tissue. Integrin-β7 is notably the target for a current IBD therapy with humanized monoclonal antibodies Vedolizumab and Etrolizumab. 95 
| A DC-specific upregulation of negative immune response regulators
Of the phagocytes sampling apoptotic IEC, CD103 + DC upregulated genes involved in the negative regulation of inflammatory signaling. 39 Notably, CD103 + DC appeared to be the only cells to do so. A common feature of the negative regulators is that they target more than 
| METABOLIC HOMEOSTASIS IN PHAGOCYTES POST AN APOPTOTIC CELL MEAL
When macrophages internalize apoptotic cells, they acquire the lipids, carbohydrates, protein, and nucleotides from the apoptotic cell.
This content increases depending on the number of apoptotic cells a macrophage ingests, and poses a significant metabolic burden on the macrophage. 144 Several studies have now shed light on the metabolic changes macrophages undergo to restore normal cellular function and homeostasis.
| Increased lipid metabolism
Cholesterol derived from an engulfed apoptotic cell becomes incor- In turn, a small fraction of HDL, called Preβ-1 HDL, interacts with ABCA1 to remove cholesterol and phospholipids from cells. 151 The exposure of PS on apoptotic cells is necessary and sufficient for both the upregulation of ABCA1 expression and the efflux of cholesterol. 145 PS-dependent cholesterol efflux also requires the activity of PPARγ and LXR, suggesting communication between these nuclear receptors and PS-recognizing engulfment receptors. 145 Evidence to date shows that signaling through the PS-specific phagocytic receptor BAI1 contributes to ABCA1 upregulation, albeit this was independent of LXR. 149 In macrophages, PPARγ controls the expression of CD36, transglutaminase-2, pentraxin-3, and Axl, all of which facilitate apoptotic cell phagocytosis. 146, 152 PPARδ controls the expression of bridge molecules such as C1qb, Gas6, and Thrombospondin-1, and its deletion impairs the phagocytosis of apoptotic cells. 91 Similarly, apoptotic cell clearance was reduced in macrophages deficient for both LXRα and LXRβ. 87 Heterodimerization of RXRα with PPARγ or LXR also controls the expression of Mer. 85, 87 Apoptotic cell uptake induces macrophage expression of uncoupling protein 2 (UCP2), 153 a finding that reflects the ability of fatty acids, such as those derived from apoptotic cells, to enhance Ucp2 transcription through the activation of PPARs 154, 155 and the sterol regulatory element binding protein (SREBP). 155, 156 UCP2 is a mitochondrial anion carrier protein that uncouples oxidative phosphorylation from ATP production by dissipating protons across the inner mitochondrial membrane, and also decreases reactive oxygen species (ROS) produced by electron transport. 155 Fatty acids also regulate the activity of UCP2 by increasing its proton conductance across inner mitochondrial membranes. 157 By lowering mitochondrial membrane potential, which inversely controls engulfment capacity, UCP2 enables macrophages to internalize more than one apoptotic cell at a time. Mutations in Acadsb are associated with a rare inherited metabolic disorder, 2-methylbutyrylglycinuria, which manifests in seizures and psychomotor delays from a defect in L-isoleucine catabolism.
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| Breakdown of macrophage lipid metabolismThe case of atherosclerosis
The regulation of lipid metabolism in macrophages upon phagocytosis of apoptotic cells extends past the maintenance of cell-autonomous homeostasis and occupies center stage in atherosclerosis. Elevated plasma levels of low-density lipoprotein cholesterol (LDL-C) remain a strong risk factor for atherosclerosis. 162, 163 The retention of these particles within the intima of arteries along with the production of ROS, lipid peroxidation products and inflammatory mediators, leads to the development of atherosclerotic plaques. 164 Here, foam cellsmacrophages that have ingested large amounts of cholesteryl fatty acids-accumulate along with necrotic cells arising from the failed clearance of apoptotic macrophages. Over time, the arterial wall breaks down, and the resultant activation of pro-coagulant and prothrombotic pathways precipitates occlusive thrombus formation and myocardial infarction. 164 Atherosclerosis is the culmination of interrelated events including defective resolution of the chronic inflammation triggered by lipoproteins retained in the subendothelium, defective egress of inflammatory cells and impaired clearance of apoptotic macrophages. [164] [165] [166] Notably, several of the genes involved in regulating lipid metabolism in macrophages have been closely associated with atherosclerosis.
Genetic deficiency for ABCA1 reduces the plasma levels of HDL cholesterol (HDL-C), one of the parameters associated with higher risk for cardiovascular disease. 150, 151, 167 In mouse models of atherosclerosis, macrophage-specific deletion of ABCA1 resulted in a large accumulation of cholesterol in macrophages, and exacerbated atherosclerosis in the advanced stage of disease. 168 ABCA1 also protects macrophages from undergoing apoptosis after the engulfment of apoptotic cells, and it may do so in two ways. First, the efflux of cholesterol would protect macrophages from endoplasmic reticulum stress-induced apoptosis in response to the accumulated cholesterol. 169 In fact, ABCA1
upregulation in response to apoptotic cell uptake might make macrophages resistant to the extreme conditions of cholesterol loading that they encounter within atherosclerotic lesions. 170 Second, the nascent ratios of mice fed an atherogenic Western diet. 149 Conversely, BAI1 deficiency under the same conditions resulted in significantly reduced levels of serum lipids including total cholesterol and HDL. 149 Genetic polymorphisms in UCP2 have been associated with several metabolic diseases including obesity, diabetes, and atherosclerosis. identified specific roles for these molecules within advanced atherosclerotic lesions in mouse models. [174] [175] [176] [177] [178] [179] Notably, deficiency in Axl restricted to the hematopoietic compartment of athero-prone mice did not affect plaque inflammation, apoptotic cell clearance or disease progression, and this did not appear to be due to compensatory Mer functions. 180 LXR expression in macrophages is critical for the reduction of atherosclerosis and concordantly, ligand activation of LXR and PPAR reverses atherosclerosis in mouse models. 181, 182 However, the efficacy of these agonists in preventing cardiovascular disease in humans remains to be seen. 191, 192 Phagocytosis of apoptotic cells in vitro leads to the production of TGF-β, IL-10 and the vitamin A metabolite retinoic acid. 60, [193] [194] [195] [196] [197] [198] [199] These molecules provide the cytokine milieu for the differentiation of induced T REG cells, [200] [201] [202] [203] [204] [205] [206] which arise in the periphery and comprise a population distinct from natural T REG cells that develop in the thymus. 207 One of the conserved non-coding DNA sequences (CNS1)
within the Foxp3 promoter in T REG cells is responsive to TGF-β, and TGF-β production by macrophages exposed to apoptotic cells. 240, 241 This is dependent on its downstream effector, the metabolic-stress sensing protein kinase GCN2. 241 Myeloid specific deletion of GCN2 in lupus-prone mice increases pathology and mortality while agonistdriven activation of GCN2 protects those mice from disease. 265 These results suggest that undigested apoptotic cell DNA in lysosomes gains access to the cytoplasm of the engulfing cell to activate cGAS and type I IFN production. Indeed, mice doubly deficient for DNASE2 and the 2′,3′-cGAMP-responsive protein stimulator of interferon genes (STING)-downstream of cGAS-were rescued from lethality and polyarthritis even though macrophages from these mice could not digest engulfed apoptotic cell DNA. 266 Cytoplasmic DNA sensors rather than TLR9 are involved in DNASE2 deficient mice because in the absence of DNASE2, the DNA fragments necessary to engage TLR9 are no longer generated. 267 In cells undergoing apoptosis through the mitochondrial pathway, the activation of caspases 9, 3, and 7 suppresses the production of type I IFN production in response to released mitochondrial DNA, which would otherwise activate the cGAS-STING pathway. 268, 269 This evidence collectively points to the cGAS/STING pathway as a major driver of type I IFN in response to undigested apoptotic cell-derived mitochondrial and chromosomal DNA.
| Specialization in T REG cell differentiation is restricted to apoptotic cell carrying DC
However, it is important to add a distinction here. Autoantibodies to nuclear antigens persist in DNASE2 and STING double knock-out mice, but they are no longer detectable on a background deficient for Unc93b1, the ER-associated chaperone for TLR7 and TLR9 trafficking to endosomes. 270, 271 Of note, these autoantibodies were not specific to dsDNA but to RNA-associated antigens perhaps reflecting the excessive accumulation of apoptotic cell debris containing RNAassociated autoantigens. 271 Collectively, the data reveal that lingering undigested DNA from apoptotic cells triggers a STING-dependent type I IFN response and TLR-dependent autoantibody production.
Paradoxically, STING has also been identified as a negative regulator in systemic autoimmunity driven by TLR activation. 272 The surprising evidence comes from the observation that STING deficiency in autoimmune prone MRL/lpr mice leads to the development of more severe disease and shorter lifespan. 273 In line with these findings, STING deletion abrogates the hallmark apoptotic cell-induced TGF-β, IL-10, and IDO production by DC, and these DC produce proinflammatory IL-6 instead. 274, 275 It will be important to decipher the mechanisms underlying the suppressive activities of STING in the context of autoimmunity and the response to apoptotic cells.
| IN CONCLUSION-ONE MORE ASPECT OF THE BIOLOGY OF APOPTOTIC CELL CLEARANCE IN TISSUES
The breadth of functions that phagocytes orchestrate in response to apoptotic cells is truly remarkable, as illustrated here by the plethora of homeostatic and pathological conditions impacted by each step in the process of recognizing, sampling, and internalizing apoptotic cells.
The scope is large and cannot be covered in a single review [please see
other recent reviews [276] [277] [278] [279] ]. One final point to make pertains to the additional role that non-professional phagocytes, such as epithelial cells, play in the clearance of apoptotic cells. This has been documented in the respiratory, colonic, and postweaning mammary epithelium. [280] [281] [282] [283] [284] To add yet another layer of complexity, macrophages also play a role in this setting. During phagocytosis of apoptotic cells or under inflammatory conditions, macrophages release insulin-like growth factor 1 (IGF-1), which binds to IGF-1 receptor (IGF1R) specifically expressed on epithelial cells and decreases their appetite for apoptotic cells. 285 Macrophages also release microvesicles and through IGF-1 redirect epithelial cells toward internalizing microvesicles instead. 285 The preferential uptake of microvesicles over apoptotic cells serves to suppress epithelial cell inflammatory responses, and accordingly the deletion of IGF1R in airway epithelial cells exacerbates airway inflammation. 285 Macrophage-derived microvesicles may contain antiinflammatory mediators such as SOCS1 and SOCS3 proteins that were reported to be present within microvesicles released by alveolar macrophages. 286 These proteins attenuated JAK-STAT signaling in alveolar epithelial cells during smoking-induced lung inflammation. 286 There are undoubtedly many more ways in which phagocytes suppress inflammation, mediate immune tolerance, and orchestrate tissue homeostasis. 
